Structure-enabled discovery of carboxylate esters prodrugs as potential potent inhibitors targeting Glutaminase C
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2025.109293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Hanyu Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chines…. Hauptthemen laut MEDLINE: Prodrugs, Glutaminase, Antineoplastic Agents, Enzyme Inhibitors. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Natural Science Foundation of China, Chinese Academy of Meteorological Sciences.
Abstract (Originalsprache)
The role of glutaminase C (GAC) in regulating glutaminolysis has established it as a promising therapeutic target for cancer treatment, driving increased interest in GAC inhibitors in recent years. The mitochondrial localization of GAC presents a particular challenge for balancing high target binding affinity with effective delivery to its subcellular site. Our previous study identified a basic hotspot within the allosteric pocket of GAC, which could be leveraged to enhance binding affinity. Herein, a series of acidic derivatives targeting the basic hotspot were designed based on the scaffold of CB839. This was followed by the development of prodrugs based on carboxylic acid inhibitors 9 and 11 to improve their lipophilicity. Prodrug 16 showed pronounced antiproliferative activity in A549 cells (IC50 = 2.45 nM) alongside favorable stability, and additionally regulated cellular metabolites and increased reactive oxygen species by blocking glutamine metabolism. Ultimately, prodrug 16 exhibits strong in vivo antitumor activity in an A549 xenograft model, establishing it as a highly potent GAC inhibitor and suggesting a novel approach for the development of next-generation GAC-targeting therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, PR China; Beijing Key L…
- State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, PR China.
- State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, PR China. Electronic ad…
Förderung
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- National Natural Science Foundation of China
- Chinese Academy of Meteorological Sciences
Zitieren
APA
Sun, H., Li, S., Mao, C., Liu, X., Ye, L., Yan, J., Chen, X., Wang, B., Du, T., & Wang, X. (2026). Structure-enabled discovery of carboxylate esters prodrugs as potential potent inhibitors targeting Glutaminase C. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.109293
Vancouver
Sun H, Li S, Mao C, Liu X, Ye L, Yan J, et al. Structure-enabled discovery of carboxylate esters prodrugs as potential potent inhibitors targeting Glutaminase C. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2025.109293
BibTeX
@article{Sun2026,
author = {Sun, Hanyu and Li, Shize and Mao, Chengxia and Liu, Xue and Ye, Lisha and Yan, Jingjie and Chen, Xiaoguang and Wang, Baolian and Du, Tingting and Wang, Xiaojian},
title = {Structure-enabled discovery of carboxylate esters prodrugs as potential potent inhibitors targeting Glutaminase C},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2025.109293}
}
EUVIMED